Source: International Congress 2018 – COPD phenotypes: a1 antitrypsin deficiency and beyond
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Strange (Charleston, United States of America), N. McElvaney (Dublin, Ireland), C. Vogelmeier (Marburg, Germany), M. Fries (King of Prussia, United States of America), J. Shah (King of Prussia, United States of America), A. Shebl (Marburg, Germany), O. Vit (Bern, Switzerland), M. Wencker (Loerzweiler, Germany), K. Chapman (Toronto, Canada). Effect of exacerbations on lung density in alpha-1 antitrypsin deficiency: Subgroup analysis of the RAPID trial programme. 568

Member's Comments

No comment yet.

Related content which might interest you: The effect of exacerbations on lung density in relation to patient characteristics in the RAPID-RCT trial of alpha-1 antitrypsin therapy Source: Virtual Congress 2021 – Novel imaging analysis methodologies in diffuse lung diseases Year: 2021 COPD and alpha-1 antitrypsin deficiency emphysema: characteristics and survival after Lung Transplantation Source: International Congress 2018 – Moving lung transplantation forward Year: 2018 Patterns of exacerbations in alpha 1 antitrypsin deficiency (AATD) Source: International Congress 2015 – Connective tissue disorders Year: 2015 Comparison of exercise training responses in COPD patients with and without Alpha-1 antitrypsin deficiency Source: International Congress 2018 – Latest advances in pulmonary rehabilitation assessment and content Year: 2018 Alpha-1 antitrypsin deficiency in COPD patients: Time to count it in! Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 LATE-BREAKING ABSTRACT: Long-term efficacy of A1-PI therapy in RAPID and RAPID extension trials Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment Year: 2015 Role of bronchiectasis in alpha1-antitrypsin deficiency patients: a comparative analysis Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions Year: 2019 Reduction in incidence of exacerbations in patients with alpha 1 antitrypsin deficiency (A1ATD) treated with concentrates of alpha 1 antitrypsin (A1AT): REXA study Source: Annual Congress 2011 - Biomarkers and exacerbations of asthma and COPD Year: 2011 Assessment of A1-PI dose-exposure and exposure-response relationships in patients with Alpha-1 antitrypsin inhibitor deficiency Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Impact of alpha-1 antitrypsin level on longitudinal lung function change: The Nagahama Study Source: International Congress 2019 – Clinical problems from non-malignant pleural disease to hypoventilation Year: 2019 Clinical features of alpha one antitrypsin deficiency in COPD Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management Year: 2012 Implementation of screening program for alpha-1 antitrypsin deficiency in Spain Source: Annual Congress 2004 - Emphysema and oxygen therapy Year: 2004 Differences in training response between patients with alpha-1 antitrypsin deficiency and COPD patients Source: International Congress 2015 – Best abstracts in functional capacity in chronic lung diseases Year: 2015 Late Breaking Abstract - Extrafine triple therapy reduces exacerbations in GOLD B COPD patients: post-hoc analysis of TRILOGY and TRINITY Source: International Congress 2017 – Update and new perspectives in Airway Diseases Year: 2017 Change in lung function and CT lung density in alpha1 antitrypsin deficiency patients under augmentation therapy Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 Population pharmacokinetics of A1-PI in patients with Alpha-1 antitrypsin deficiency Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Predicting clinical course of alpha 1 anti-trypsin deficiency (AATD) using GOLD 2011 classification Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 Screening for alpha-1 antitrypsin deficiency in Polish lung or liver disease patients Source: Annual Congress 2011 - Lung development and neoplasia Year: 2011 Functional alterations of small airways in patients with alpha-1 antitrypsin deficiency (AATD) in a longitudinal study Source: Eur Respir J 2005; 26: Suppl. 49, 361s Year: 2005 Exercise intolerance and lung emphysema in alpha-1 antitrypsin deficiency (AATD) Source: Annual Congress 2010 - Exercise in COPD Year: 2010